Literature DB >> 10926939

Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke.

I Christou1, A V Alexandrov, W S Burgin, A W Wojner, R A Felberg, M Malkoff, J C Grotta.   

Abstract

BACKGROUND: The duration of cerebral blood flow impairment correlates with irreversibility of brain damage in animal models of cerebral ischemia. Our aim was to correlate clinical recovery from stroke with the timing of arterial recanalization after therapy with intravenous tissue plasminogen activator (tPA).
METHODS: Patients with symptoms of cerebral ischemia were treated with 0.9 mg/kg tPA IV within 3 hours after stroke onset (standard protocol) or with 0.6 mg/kg at 3 to 6 hours (an experimental institutional review board-approved protocol). National Institutes of Health Stroke Scale (NIHSS) scores were obtained before treatment, at the end of tPA infusion, and at 24 hours; Rankin Scores were obtained at long-term follow-up. Transcranial Doppler (TCD) was used to locate arterial occlusion before tPA and to monitor recanalization (Marc head frame, Spencer Technologies; Multigon 500M, DWL MultiDop-T). Recanalization on TCD was determined according to previously developed criteria.
RESULTS: Forty patients were studied (age 70+/-16 years, baseline NIHSS score 18.6+/-6.2). A tPA bolus was administered at 132+/-54 minutes from symptom onset. Recanalization on TCD was found at the mean time of 251+/-171 minutes after stroke onset: complete recanalization occurred in 12 (30%) patients and partial recanalization occurred in 16 (40%) patients (maximum observation time 360 minutes). Recanalization occurred within 60 minutes of tPA bolus in 75% of patients who recanalized. The timing of recanalization inversely correlated with early improvement in the NIHSS scores within the next hour (polynomial curve, third order r(2)=0.429, P<0.01) as well as at 24 hours. Complete recanalization was common in patients who had follow-up Rankin Scores if 0 to 1 (P=0.006). No patients had early complete recovery if an occlusion persisted for >300 minutes.
CONCLUSIONS: The timing of arterial recanalization after tPA therapy as determined with TCD correlates with clinical recovery from stroke and demonstrates a 300-minute window to achieve early complete recovery. These data parallel findings in animal models of cerebral ischemia and confirm the relevance of these models in the prediction of response to reperfusion therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926939     DOI: 10.1161/01.str.31.8.1812

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  52 in total

Review 1.  Critical care of acute ischemic stroke.

Authors:  R A Bernstein; J C Hemphill
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 5.081

Review 2.  Advanced imaging application for acute ischemic stroke.

Authors:  Jeffrey Farkas; Andrew Xavier; Charles J Prestigiacomo
Journal:  Emerg Radiol       Date:  2004-12

3.  Combination treatment with rt-PA is more effective than rt-PA alone in an in vitro human clot model.

Authors:  Jason M Meunier; Christy K Holland; Tyrone M Porter; Christopher J Lindsell; George J Shaw
Journal:  Curr Neurovasc Res       Date:  2011-11       Impact factor: 1.990

4.  Brain attack.

Authors:  Robert A Felberg
Journal:  Ochsner J       Date:  2003

5.  Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-08-29       Impact factor: 6.829

Review 6.  Taking a light approach to treating acute ischemic stroke patients: transcranial near-infrared laser therapy translational science.

Authors:  Paul A Lapchak
Journal:  Ann Med       Date:  2010-11-01       Impact factor: 4.709

7.  Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model.

Authors:  Juergen Bardutzky; Xianjun Meng; James Bouley; Timothy Q Duong; Rajiv Ratan; Marc Fisher
Journal:  J Cereb Blood Flow Metab       Date:  2005-08       Impact factor: 6.200

8.  Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke.

Authors:  Hélène N David; Benoît Haelewyn; Jean-Jacques Risso; Nathalie Colloc'h; Jacques H Abraini
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

9.  Factors Associated with Thrombolysis Outcome in Ischemic Stroke Patients with Atrial Fibrillation.

Authors:  Qiuyun Zhao; Xiaobo Li; Wanli Dong; Min Ye; Yongjun Cao; Meijuan Zhang; Qiantao Cheng; Junshan Zhou; Guofang Chen; Ming Yu; Shanshan Hong; Xiue Wei; Bei Wang; Guiyun Cui; Peng Zhang; Hong Ding; Rongzhen Xu; Yan Chen; Yun Xu
Journal:  Neurosci Bull       Date:  2016-03-07       Impact factor: 5.203

10.  Good clinical outcome after ischemic stroke with successful revascularization is time-dependent.

Authors:  P Khatri; T Abruzzo; S D Yeatts; C Nichols; J P Broderick; T A Tomsick
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.